Skip to main content
. 2016 Nov 18;95(46):e5202. doi: 10.1097/MD.0000000000005202

Figure 2.

Figure 2

(A) Forest plot of myeloma overall response with bortezomib-based versus non–bortezomib-based treatment for MM patients with renal insufficiency. (B) Forest plot of myeloma complete response with bortezomib-based versus non–bortezomib-based treatment for MM patients with renal insufficiency. CI = confidence interval, control = non–bortezomib-based treatment, experimental = bortezomib-based treatment, MM = multiple myeloma.